Table 7.
Title | TC | Year | TC/Year | Journal | Mesh Terms | Authors |
---|---|---|---|---|---|---|
Curcumin as “Curecumin”: From kitchen to clinic | 1725 | 2008 | 123.21 | Biochemical Pharmacology | Anticancer; Curcumin; Natural products | Goel A et al. |
Medicinal plants of India with anti-diabetic potential | 1304 | 2002 | 65.2 | Journal of Ethnopharmacology | Ayurveda; Diabetes mellitus; Herbal medicine; Indian; Plants; Review | Grover J.K et al. |
Medicinal plants: Traditions of yesterday and drugs of tomorrow | 1260 | 2006 | 78.75 | Molecular Aspects of Medicine | Drug discovery; Ethnobotany; Medicinal plants; Pharmacognosy; Traditional medicine; Validation | Gurib-Fakim A. |
The anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept.’ | 1082 | 2006 | 67.63 | Journal of Ethnopharmacology | Antibacterial; Antifungal; Antiparasitic; Antiviral; Natural products; Screening | Cos P et al. |
Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research | 1055 | 2009 | 81.15 | Alternative Medicine Review | Jurenka J.S. | |
Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research | 1027 | 2008 | 73.36 | Food and Chemical Toxicology | Anti-emetic; Anti-inflammatory; Anti-oxidant; Anti-tumorigenic; Ginger; Gingerols | Ali B.H et al. |
Herb-drug interactions | 1021 | 2000 | 46.41 | Lancet | Fugh-Berman A. | |
Silver nanoparticles: The powerful nano weapons against multidrug-resistant bacteria | 1000 | 2012 | 100 | Journal of Applied Microbiology | Antimicrobial; Methicillin-resistant Staphylococcus aureus; Multidrug resistance; Nanoweapon; Silver nanoparticles; Vancomycin-resistant Staphylococcus aureus. | Rai M.K et al. |
Traditional medicine and modern medicine from natural products | 919 | 2016 | 153.17 | Molecules | Chemodiversity; Drug discovery; Natural products; Traditional medicines; Traditional uses | Yuan H et al. |
Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC | 883 | 2012 | 88.3 | The Lancet Oncology | Caraceni A et al. |
Note: TC – total citations; TC/Y – average citations per year.